About Index Trending news
Analyze
Top 50 Pricing
LPATH

LPATH

LPATH

Lpath, Inc. is the category leader in the discovery and development of monoclonal antibodies that target (neutralize) bioactive lipids. The

Elsewhere

Alexa global traffic share

Twitter followers

07 Oct 2014
$12,527,521
Venture capital
19 Sep 2014
$12,500,000
Post-IPO equity